BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 475846)

  • 1. Cyclophosphamide cystitis--identification of acrolein as the causative agent.
    Cox PJ
    Biochem Pharmacol; 1979 Jul; 28(13):2045-9. PubMed ID: 475846
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide cystitis. Studies aimed at its minimization.
    Cox PJ; Abel G
    Biochem Pharmacol; 1979 Dec; 28(24):3499-502. PubMed ID: 231445
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental cytoxan cystitis and prevention by acetylcysteine.
    Chaviano AH; Gill WB; Ruggiero KJ; Vermeulen CW
    J Urol; 1985 Sep; 134(3):598-600. PubMed ID: 4032564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of interleukin-6-regulated nitric oxide synthase in hemorrhagic cystitis and impaired bladder contractions in young rats induced by acrolein, a urinary metabolite of cyclophosphamide.
    Wang CC; Weng TI; Wu ET; Wu MH; Yang RS; Liu SH
    Toxicol Sci; 2013 Jan; 131(1):302-10. PubMed ID: 22961095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of N-acetylcysteine on cyclophosphamide immunoregulation and antitumor activity.
    Levy L; Vredevoe DL
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):7-16. PubMed ID: 6836330
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide-induced cystitis of the urinary bladder of rats and its treatment.
    Tolley DA; Castro JE
    Proc R Soc Med; 1975 Mar; 68(3):169-70. PubMed ID: 1166056
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of COX-2 expression by acrolein in the rat model of hemorrhagic cystitis.
    Macedo FY; Baltazar F; Mourão LC; Almeida PR; Mota JM; Schmitt FC; Ribeiro RA
    Exp Toxicol Pathol; 2008 Apr; 59(6):425-30. PubMed ID: 18234483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat urinary bladder epithelial lesions induced by acrolein.
    Sakata T; Smith RA; Garland EM; Cohen SM
    J Environ Pathol Toxicol Oncol; 1989; 9(2):159-69. PubMed ID: 2732910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.
    Conklin DJ; Haberzettl P; Lesgards JF; Prough RA; Srivastava S; Bhatnagar A
    J Pharmacol Exp Ther; 2009 Nov; 331(2):456-69. PubMed ID: 19696094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats.
    Harrison EF; Fuquay ME; Hunter HL
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):25-8. PubMed ID: 6836324
    [No Abstract]   [Full Text] [Related]  

  • 11. A model of hemorrhagic cystitis induced with acrolein in mice.
    Batista CK; Brito GA; Souza ML; Leitão BT; Cunha FQ; Ribeiro RA
    Braz J Med Biol Res; 2006 Nov; 39(11):1475-81. PubMed ID: 17146560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of cyclophosphamide-induced cystitis in mice by disulfiram.
    Hacker MP; Newman RA; Ershler WB
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):145-54. PubMed ID: 7058285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors mediate DNA damage repair in ameliorating hemorrhagic cystitis.
    Haldar S; Dru C; Mishra R; Tripathi M; Duong F; Angara B; Fernandez A; Arditi M; Bhowmick NA
    Sci Rep; 2016 Dec; 6():39257. PubMed ID: 27995963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder.
    Ahluwalia A; Maggi CA; Santicioli P; Lecci A; Giuliani S
    Br J Pharmacol; 1994 Apr; 111(4):1017-22. PubMed ID: 8032584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis.
    Malley SE; Vizzard MA
    Physiol Genomics; 2002; 9(1):5-13. PubMed ID: 11948286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy.
    Gray KJ; Engelmann UH; Johnson EH; Fishman IJ
    J Urol; 1986 Aug; 136(2):497-500. PubMed ID: 3090278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
    Brock N; Stekar J; Pohl J; Niemeyer U; Scheffler G
    Arzneimittelforschung; 1979; 29(4):659-61. PubMed ID: 114192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcysteine in the prevention of cyclophosphamide-induced cystitis in rats.
    Botta JA; Nelson LW; Weikel JH
    J Natl Cancer Inst; 1973 Sep; 51(3):1051-8. PubMed ID: 4743552
    [No Abstract]   [Full Text] [Related]  

  • 19. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
    Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A; Korkmaz A; Oter S; Coskun O
    Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.